Corrigendum to "Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia" [Bioact. Mater. 21 (March 2023) 499-510].
Where this comes from
- Record sourced from PubMed, PMID 37637085.
- Also identified by DOI 10.1016/j.bioactmat.2023.08.011 and PMC identifier 10458256.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].